wearable health tech
Misusing wearable health tech, especially continuous glucose monitors, can accelerate metabolic aging rather than prevent it. When data is ignored, misinterpreted, or poorly calibrated, the device becomes a hidden antagonist to longevity. In the 12-month BioHack Labs pilot, elite athletes saw an 18% drop in insulin resistance by aligning nutrition
science communication strategy
Documentary Exposes The Balkan Bet On Longevity Science In 2023 the Belgrade startup invested €150,000 in a documentary to prove its longevity science can compete with Western labs, and the film is now opening doors in Cambridge. The film weaves personal struggle with cutting-edge genetics, aiming to convince investors
translational longevity research
Reveal 5 Longevity Science Failures Blocking FDA Approval In 2025, Harvard researchers showed a senolytic cocktail extended mouse healthspan by 23%, yet most anti-aging candidates never clear early regulatory hurdles. The five biggest failures that keep promising molecules stuck in petri dishes and mouse studies are safety validation gaps, weak
Healthspan Optimization
The seven science-backed secrets that shorten healthspan are poor biomarker use, misguided wearables, ignoring biological age, data paralysis, and an overfocus on lifespan metrics. In 2025, Immorta Bio reported a 22% drop in age-related disease onset among participants who monitored epigenetic clocks. That same year, wearable heart-rate variability trackers boosted
resveratrol human trials
Anti-aging supplements do not magically stop aging, and most of the hype rests on shaky evidence. I sift through peer-reviewed studies, animal-human gaps, and funding sources to reveal which claims survive scrutiny. 28 double-blind studies published between 2015 and 2023 show only 12% of anti-aging supplements improve health-span biomarkers. Medical
longevity science
You’re getting seven key longevity myths wrong, and here’s what the science actually says. I break down the hype, cite the data, and give you practical steps you can trust. 13 researchers presented at the 2023 ARDD conference, yet only four of the 22 AI-predicted drug candidates moved
metformin for longevity
Yes, Metformin shows promise as a longevity tool, but the evidence is mixed and the safety profile demands careful medical oversight. In 2023, a meta-analysis of 18 cohort studies found Metformin users had a 15% lower risk of all-cause mortality, sparking intense interest from biotech investors and biohackers alike. Medical
the key to longevity
Yes. The longevity market burns money on flashy promises while the most reliable, cost-effective science remains simple lifestyle habits. Consumers and investors alike often chase unproven bio-hacks, leaving a gap between marketing hype and measurable health benefits. In 2022, the anti-aging sector attracted unprecedented attention from investors, sparking a wave
longevity science explained
Longevity science works by translating the findings of the 13th ARDD meeting into practical strategies that improve healthspan, not just lifespan. The 13th ARDD meeting gathered leading researchers from institutions such as Calico Life Sciences and Insilico Medicine to map the biology of aging. Medical Disclaimer: This article is for
senolytic supplements safety
Senolytic supplements like fisisk and quercetin do not reliably clear senescent cells and may expose users to unforeseen health risks. While the market touts anti-aging miracles, the scientific record shows mixed results and safety gaps. 22% increase in inflammatory markers after six weeks of unsupervised quercetin dosing. Medical Disclaimer: This
longevity science
Only about 5% of longevity science supplements show measurable health benefits, so you should stop using them. The hype around "fountain-of-youth" pills masks modest effects and hidden risks, especially when real-world data reveal little impact on lifespan or vitality. Medical Disclaimer: This article is for informational purposes only
epigenetic programming executives
Relying on DNA alone is an incomplete strategy for extending executive lifespans; the real leverage lies in epigenetic programming and integrated bio-hacks that keep the whole cellular system in balance. Companies that focus only on genetic predispositions miss the actionable levers that drive measurable healthspan improvements for their leaders. In